Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
We were having cocktails at...
Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.
Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...
Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?
Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com)
AKA, you'd have to have your head examined...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a...
Adding Hepion Pharma (HEPA) $1.73 to Watch List.
Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here?
Oh my…and Oh boy....
Video: Famed Shortseller Marc Cohodes Crazy Over Overstock (OSTK).
Two video interviews with Marc Cohodes, formerly with Rocker Partners.
Overstock (OSTK), Overstock Preferred (OSTKO), T-ZERO (TZROP)Camping World...
Oh, No. Alcohol-Based Sanitizers Losing Effectiveness Against Superbugs.
Hospital hand sanitizers not potent enough for superbug (Science)
Bacterial superbugs are becoming increasingly tolerant of alcohol, the...
SinoFresh. One-Stop E-Commerce OTC Health & Wellness Pharmacy
https://youtu.be/axnge8NPH1s
Aphex BioCleanse (SNST) Making Serious Headlines.
Relatively quiet for most of the year. Aphex BioCleanse, our favorite Super Bug sanitizer company, made two back-to-back announcements - signaling things...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
